[用于治疗严重喘的全身葡萄皮质类药物的使用:西班牙多学科共识]
Javier Domínguez-Ortega1,2, Julio Delgado Romero3, Xavier Muñoz Gall2,4
1Departamento de Alergia, Hospital La Paz, Instituto de Investigación IDiPAZ, Madrid, España.
Open respiratory archives
|July 27, 2023
概括
为了尽量减少骨质疏松症等副作用,专家建议在严重喘管理中减少口服皮质类固醇 (OCS) 的使用. 在维护治疗中建议采用缓慢,渐进的逐渐缩减策略.
科学领域:
- 肺部病理学 肺部病理学
- 过敏学 过敏学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口服皮质类固醇 (OCS) 是标准的喘治疗方法,但与骨质疏松症和上腺功能不全等副作用有关.
- 优化OCS使用对于管理严重喘和减轻不良事件至关重要.
研究的目的:
- 建立专家共识,减少口服皮质类固醇 (OCS) 在严重喘管理使用.
- 提供科学支持的建议,以尽量减少与OCS相关的不良影响.
主要方法:
- 使用德尔菲方法的观测研究.
- 两轮68项问卷由48名过敏学家和肺病学家填写.
主要成果:
- 专家们就定义和在严重喘中最佳使用OCS达成一致.
- 达成共识,尽量减少OCS,在维护中采用缓慢的逐渐缩小,并标准化交付测量.
结论:
- 本共识文件提供了由专家支持的战略,以减少西班牙的OCS使用.
- 专注于尽量减少OCS,并优化严重喘患者的治疗方案.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
300
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
300
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
Asthma: Pathogenesis and Management
447
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
447
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


